Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
29.68
-1.93 (-6.09%)
Mar 20, 2026, 11:48 AM EDT - Market open
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $1.44 billion as of March 20, 2026. Its market cap has increased by 829.11% in one year.
Market Cap
1.44B
Enterprise Value
1.47B
1-Year Change
829.11%
Ranking
Category
Stock Price
$29.68
Market Cap Chart
Since the IPO on November 21, 2016, Nanobiotix's market cap has increased from $249.91M to $1.44B, an increase of 474.81%. That is a compound annual growth rate of 20.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 1.53B | 38.28% |
| Dec 31, 2025 | 1.11B | 646.33% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harmony Biosciences Holdings | 1.64B |
| Innoviva | 1.63B |
| Sionna Therapeutics | 1.61B |
| Iovance Biotherapeutics | 1.60B |
| Oculis Holding AG | 1.59B |
| Intellia Therapeutics | 1.59B |
| Nurix Therapeutics | 1.59B |
| Generate Biomedicines | 1.58B |